-+ 0.00%
-+ 0.00%
-+ 0.00%

Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common shares

PUBT·09/21/2026 20:06:03
Listen to the news
Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common shares
  • Twist Bioscience CEO Emily M. Leproust exercised employee stock options for 208,708 shares on Sept. 17, 2026.
  • She sold 356,546 shares the same day at weighted average prices ranging from $151.46 to $163.39.
  • Her direct holding fell to 620,589 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-011832), on September 21, 2026, and is solely responsible for the information contained therein.